The behavioural response of NK1R-/- mice to guanfacine resembles its clinical profile in treatment of ADHD.

The behavioural response of NK1R-/- mice to guanfacine resembles its clinical profile in treatment of ADHD.

Br J Pharmacol. 2014 Jul 29;

Authors: Pillidge K, Porter AJ, Dudley JA, Tsai YC, Heal DJ, Stanford SC

Abstract
BACKGROUND: Mice with functional ablation of substance P-preferring neurokinin-1 receptors (NK1R-/-) display behavioural abnormalities resembling those seen in Attention Deficit Hyperactivity Disorder (ADHD). Here, we investigated whether the ADHD treatment, guanfacine, alleviates the hyperactivity and impulsivity/inattention displayed by NK1R-/- mice in the light/dark exploration box (LDEB) and 5-Choice Serial Reaction-Time Task (5-CSRTT), respectively. Prompted by reports of comorbid anxiety in ADHD, we also investigated the effects of guanfacine on anxiety-like behaviour displayed by NK1R-/- and wildtype mice in the elevated plus-maze (EPM).
METHODS: Mice were tested in the 5-CSRTT after treatment with guanfacine (0.1, 0.3 or 1 mg/kg, i.p.), vehicle or no injection. Separate cohorts of mice were tested in the LDEB after the same treatments and in the EPM with the lowest dose of guanfacine.
RESULTS: A low dose of guanfacine (0.1 mg/kg) increased attention in NK1R-/- mice, but not wildtypes, in the 5-CSRTT. This dose did not affect the total number of trials completed, latencies to respond or locomotor activity in the LDEB. Impulsivity was decreased by the high dose (1 mg/kg) of guanfacine, but this was evident in both genotypes and is likely to be secondary to a generalized blunting of behaviour. Although the NK1R-/- mice displayed marked anxiety-like behaviour, guanfacine did not affect the behaviour of either genotype in the EPM.
CONCLUSIONS: This evidence that guanfacine improves attention at a dose that does not affect arousal or emotionality, supports our proposal that NK1R-/- mice express an attention deficit that resembles that of ADHD patients.

PMID: 25074741 [PubMed – as supplied by publisher]

via http://ift.tt/1m0iYz6